News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
255,420 Results
Type
Article (13692)
Company Profile (202)
Press Release (241526)
Section
Business (79385)
Career Advice (144)
Deals (13238)
Drug Delivery (26)
Drug Development (50105)
Employer Resources (31)
FDA (5617)
Job Trends (5121)
News (143846)
Policy (10067)
Tag
Academia (902)
Africa (147)
Alabama (22)
Allergies (28)
Alliances (21475)
ALS (14)
Alzheimer's disease (654)
Antibody-drug conjugate (ADC) (27)
Approvals (5592)
Arizona (39)
Artificial intelligence (21)
Asia (16638)
Australia (2767)
Bankruptcy (96)
Best Places to Work (4298)
Biosimilars (16)
C2C Services and Suppliers (10807)
California (523)
Canada (344)
Cancer (99)
Career advice (128)
CAR-T (25)
Cell therapy (55)
China (24)
Clinical research (38649)
Collaboration (40)
Colorado (17)
COVID-19 (963)
Cystic fibrosis (56)
Data (15)
Diabetes (14)
Diagnostics (1141)
Drug pricing (17)
Duchenne muscular dystrophy (15)
Earnings (28118)
Employer resources (29)
Europe (35471)
Events (45438)
Executive appointments (19)
FDA (5638)
Florida (47)
Funding (26)
Gene editing (16)
Gene therapy (46)
GLP-1 (242)
Government (1052)
Healthcare (6539)
Hotbed/Location (185370)
Idaho (16)
Illinois (35)
Indiana (36)
Infectious disease (966)
Inflammatory bowel disease (74)
Interviews (15)
IPO (7124)
Job creations (864)
Job search strategy (124)
Kansas (48)
Layoffs (170)
Legal (1384)
Liver cancer (23)
Lung cancer (18)
Maryland (116)
Massachusetts (272)
Medical device (2557)
Medtech (2557)
Mergers & acquisitions (6045)
Metabolic disorders (81)
Neuroscience (711)
New Jersey (35)
New York (46)
NextGen Class of 2024 (1972)
Non-profit (841)
North Carolina (70)
Obesity (51)
Opinion (80)
Parkinson's disease (24)
Peanut (25)
Pennsylvania (22)
People (24656)
Phase I (13570)
Phase II (17983)
Phase III (11439)
Podcasts (14)
Policy (15)
Postmarket research (842)
Preclinical (5731)
Rare diseases (71)
Real estate (1420)
Regulatory (7953)
Research institute (926)
Resumes & cover letters (16)
Series A (16)
South America (207)
Startups (1963)
Texas (27)
United States (1488)
Vaccines (103)
Washington State (71)
Weight loss (42)
Date
Today (33)
Last 7 days (263)
Last 30 days (1078)
Last 365 days (21978)
2024 (12491)
2023 (22501)
2022 (26930)
2021 (27940)
2020 (23504)
2019 (16327)
2018 (11818)
2017 (13799)
2016 (11887)
2015 (14384)
2014 (10426)
2013 (7531)
2012 (7608)
2011 (7711)
2010 (7507)
255,420 Results for "genesis therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
Celebrating Its Fifth Anniversary, Genesis Reference Laboratories Announces Testing Upgrades
Genesis Reference Laboratories, a leading diagnostics laboratory, is pleased to announce upgrades to its testing menus.
February 8, 2024
·
3 min read
Business
Tim Czartoski Appointed as CEO of Genesis Innovation Group
Genesis Innovation Group is excited to announce the appointment of Tim Czartoski as Chief Executive Officer effective April 1, 2024, and serving in an advisory role until that time.
January 22, 2024
·
3 min read
Biotech Bay
Genesis Therapeutics Closes Oversubscribed $200 Million Series B
Genesis Therapeutics, a company pioneering artificial intelligence (AI) technologies to create breakthrough medicines for patients with severe diseases, announced today that it has closed an oversubscribed $200 million round of Series B financing.
August 21, 2023
·
5 min read
Advancing Healthcare Access: Genesis MedTech Teams Up with Silk Road Medical to Serve Patients affected by Carotid Artery Disease in China
Silk Road Medical, a medical device company based in California USA and Genesis MedTech Group have signed an exclusive distribution agreement to introduce the TCAR® core products, ENROUTE® Transcarotid Neuroprotection System and ENROUTE® Transcarotid Stent System, in China.
March 7, 2024
·
5 min read
Biotech Bay
Genesis MedTech Completes Enrollment in its United States Early Feasibility Study Utilizing the J-Valve™ Transfemoral System for Patients with Severe Aortic Regurgitation
Genesis MedTech, a leading medical device company, today announced the completion of enrollment in its United States Early Feasibility Study (EFS) using its dedicated transcatheter aortic valve replacement (TAVR) system, J-Valve™ Transfemoral (TF) System.
February 5, 2024
·
3 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
3 min read
·
Voyager Therapeutics, Inc.
Deals
Genesis Drug Discovery & Development (GD3), a Member of Genesis Global Group, Acquires JSS Medical Research to Expand its Clinical Services Portfolio
Genesis Drug Discovery and Development, Contract Research Organization arm and member of Genesis Global Group, announced that it has acquired JSS Medical Research.
May 10, 2023
·
4 min read
Genesis MedTech introduces China’s first domestic brand of NPMA-approved antibacterial sutures
Genesis MedTech, a leading medical device company, today announced that its absorbable sutures with antibacterial protection have successfully obtained approval from the China’s National Medical Products Administration (NMPA) for market release.
September 11, 2023
·
2 min read
Genesis MedTech Receives Approval for Launch in China for ArtiSential™
Genesis MedTech announced that its ArtiSential™, a revolutionary series of articulating laparoscopic instruments, has successfully obtained approval from the China’s National Medical Products Administration for market release.
July 6, 2023
·
2 min read
Biotech Bay
Genesis MedTech initiates enrolment in its North American Early Feasibility Study using the J-Valve™ Transfemoral System for patients with severe aortic regurgitation
Genesis MedTech, a leading medical device company, announced initiation of enrolment in its North American Early Feasibility Study using its dedicated TAVR system, J-Valve™ Transfemoral System.
October 23, 2023
·
3 min read
1 of 25,542
Next
